Abstract:BACKGROUND: Understanding the molecular basis underlying metastasis of non-small cell lung cancer (NSCLC) may provide a new therapeutic modality for the treatment of NSCLC. However, the mechanisms by which tumor-associated macrophages (TAMs) affect NSCLC metastasis remain undefined. In this study, we aimed to discover a novel regulatory pathway involved in NSCLC metastasis.METHODS: Cell Counting Kit-8 (CCK-8), Transwell, western blot assays were used to assess cell viability, migration, invasion and epithelial-mesenchymal transition (EMT). Exosomes from macrophages medium were characterized, and in vitro cell coculture was further conducted to investigate M2 derived exosomes mediated crosstalk between TAMs and tumor cells. Besides, miRNA microarray was used to analyze miRNA expression profiles of M0 and M2 derived exosomes. Luciferase reporter assay was used to verify the potential binding between miRNA and mRNA. Moreover, 6-week-old male BALB/c nude mice were performed to establish transplantation tumor model using tail vein injection. Hematoxylin & eosin staining was used to detect the metastasis of tumor tissues.RESULTS: We found that M2 TAMs were the main TAMs in metastatic tissues of NSCLC patients and exosomes derived from M2 TAMs were able to promote cell viability, cell migration, cell invasion and EMT in NSCLC. We demonstrated that miR-155 and miR-196a-5p were abundant in M2 TAMs and exosomes secreted by M2 TAMs. Functional experiments demonstrated that the deletion of miR-155 and miR-196a-5p in M2 TAMs significantly prevented NSCLC metastasis <i>in vitro</i> and <i>in vivo</i>. To clarify the mechanism governing miR-155 and miR-196a-5p from M2 TAMs, we carried out bioinformatics analysis to predict potential target genes. Mechanistically, miR-155 and miR-196a-5p directly bound to the 3'-UTR of Ras association domain family member 4 (RASSF4), and negatively regulating RASSF4 expression. At last, rescue assays demonstrated that miR-155 and miR-196a-5p exerted its performance by RASSF4.CONCLUSIONS: Overall, we revealed a new regulatory pathway that was M2 TAMs secreted exosomal miR-155 and miR-196a-5p to promote NSCLC metastasis. This dynamic and reciprocal cross-talk between NSCLC and macrophages innovatively provided a potential opportunity for diagnosis and treatment of NSCLC.

Stromal-derived Mir-486-5p Promotes Metastasis of Non-Small-cell Lung Cancer Cells by Targeting the CADM1/tight Junctions Axis in Vascular Endothelial Cells

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

LncRNA CCDC144NL-AS1 Serves As a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting Mir-490-3p

A Serum Microrna Signature As a Prognostic Factor for Patients with Advanced NSCLC and Its Association with Tissue Microrna Expression Profiles.

Mir-1225-5p Inhibits Non-Small Cell Lung Cancer Cell Proliferation, Migration and Invasion, and May Be a Prognostic Biomarker.

Mir‑146a‑5p Targets TCSF and Influences Cell Growth and Apoptosis to Repress NSCLC Progression

Microrna-15b Promotes Proliferation and Invasion of Non-Small Cell Lung Carcinoma Cells by Directly Targeting Timp2

Effect of Mir-146A-5p on Tumor Growth in NSCLC Using Chick Chorioallantoic Membrane Assay and Bioinformatics Investigation

Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer

Tumor Invasion and Metastasis Regulated by Microrna-184 and Microrna-574-5p in Small-Cell Lung Cancer

Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer

Mir-147A Suppresses the Metastasis of Non-Small-cell Lung Cancer by Targeting CCL5

Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer.

MicroRNA-4458 suppresses migration and epithelial-mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells.

Mir-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting Rhogdi1 and Alcam

The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.

MiR-661 Promotes Tumor Invasion and Metastasis by Directly Inhibiting RB1 in Non Small Cell Lung Cancer

Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer

Exosomal and Intracellular Mir-320B Promotes Lymphatic Metastasis in Esophageal Squamous Cell Carcinoma

MicroRNA-203 Promotes the Progression of Non-Small Cell Lung Cancer Via Surviving.